Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Sildenafil for the Treatment of Sustained Pulmonary Artery Hypertension After Corrected Mitral Valve Disease

NCT02435303 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT02435303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02435303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Sildenafil for the Treatment of Sustained Pulmonary Artery Hypertension After Corrected Mitral Valve Disease
Lead sponsor
Asan Medical Center
Phase
Phase 2/3
Overall status
Terminated
Start date
May 31, 2016
Completion date
June 30, 2018
Enrollment
2 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diseases of mitral valve, hypertension, pulmonary